Beyond market averages, investors seeking exceptional growth focus on the art of stock selection. The right picks can significantly contribute to the expansion of your wealth.
As of close of business last night, NovaBridge Biosciences. ADR’s stock clocked out at $3.98, up 0.51% from its previous closing price of $3.96. In other words, the price has increased by $0.51 from its previous closing price. On the day, 0.43 million shares were traded. NBP stock price reached its highest trading level at $4.0595 during the session, while it also had its lowest trading level at $3.9.
Ratios:
To gain a deeper understanding of NBP’s stock, we examine its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 14.47 and its Current Ratio is at 14.47. In the meantime, Its Debt-to-Equity ratio is 0.01 whereas as Long-Term Debt/Eq ratio is at 0.01.
Upgrades & Downgrades
. In the most recent recommendation for this company, Leerink Partners on October 03, 2025, initiated with a Outperform rating and assigned the stock a target price of $9.
On September 09, 2025, BTIG Research started tracking the stock assigning a Buy rating and target price of $7.
On December 09, 2021, Siebert Williams Shank started tracking the stock assigning a Buy rating and target price of $96.Siebert Williams Shank initiated its Buy rating on December 09, 2021, with a $96 target price.
Insider Transactions:
Investing in insider trades can also provide an investor with insight into how management views future stock prices. A recent insider transaction in this stock occurred on Dec 18 ’25 when Dennis Phillip Andrew bought 3,431 shares for $4.23 per share.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, NBP now has a Market Capitalization of 458858304 and an Enterprise Value of 830375104.
Stock Price History:
The Beta on a monthly basis for NBP is 1.60, which has changed by 3.370861 over the last 52 weeks, in comparison to a change of 0.17511821 over the same period for the S&P500. Over the past 52 weeks, NBP has reached a high of $6.79, while it has fallen to a 52-week low of $0.60. The 50-Day Moving Average of the stock is -6.11%, while the 200-Day Moving Average is calculated to be 34.21%.
Shares Statistics:
It appears that NBP traded 1.07M shares on average per day over the past three months and 598190 shares per day over the past ten days. A total of 115.29M shares are outstanding, with a floating share count of 98.25M. Insiders hold about 14.78% of the company’s shares, while institutions hold 24.83% stake in the company. Shares short for NBP as of 1765756800 were 4250443 with a Short Ratio of 3.99, compared to 1763078400 on 4479827. Therefore, it implies a Short% of Shares Outstanding of 4250443 and a Short% of Float of 4.62.
Earnings Estimates
The stock of NovaBridge Biosciences. ADR (NBP) is currently drawing attention from 3.0 analysts actively involved in the ongoing evaluation and rating process.The consensus estimate for the next quarter is -$0.19, with high estimates of -$0.19 and low estimates of -$0.19. Analysts are recommending an EPS of between -$0.1 and -$0.61 for the fiscal current year, implying an average EPS of -$0.31. EPS for the following year is -$0.32, with 3.0 analysts recommending between -$0.21 and -$0.49.
